Having just received European CE mark certification for its Galen AI cancer diagnostic software (see here), Israel’s Ibex Medical has now been awarded “Breakthrough” designation by the US FDA. This will help fast-track clinical review and regulatory approval of its technology.
Cancer diagnostic tech is a breakthrough
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.